First order received from new Redsense distributor in the Benelux region

Report this content

Redsense Medical has signed a letter of intent and is finalizing a distribution agreement with Netherland-based Dirinco covering the Netherlands, Belgium and Luxembourg. The distributor will offer the company's alarm system together with hemodialysis machines from Redsense collaboration partners Nikkiso and NxStage. The distributor has already placed a first purchase order for Redsense systems. The first order, worth around 7 000 SEK, is for evaluation by a customer.

The expected agreement with Dirinco will constitute a switch from an earlier Netherland-based distributor as well as expanding the company’s market presence in Europe to include the whole Benelux region. The Benelux countries generally offer well-developed health care systems for its citizens, with the Netherlands receiving the highest score of all countries in the Euro Health Consumer Index 2016.

“This agreement is in line with the aim to increase our market presence in Europe through distributors that can sell the Redsense alarm system together with dialysis machines from our collaboration partners. These complete systems for hemodialysis deliver a very high level of patient safety, which gives us a strong position against competing offers”, says Patrik Byhmer, CEO of Redsense Medical.

Of the three Benelux countries, the Netherlands is the largest hemodialysis market with nearly 5 000 patients, of which nearly 300 are treated using home dialysis.

The distributor Dirinco has over 30 years of experience in offering products to customers on the dialysis market in the Netherlands, Belgium and Luxembourg. The company sells products developed inhouse as well as products from other manufacturers.

For more information, please contact
Patrik Byhmer, CEO Redsense Medical AB (publ)
Telephone: +46 (0) 35 - 10 60 30

This press release is a translation of the Swedish original that was published 2017-09-28. It was added to the Redsense news channel as a formatted document 2017-09-29 during the process of preparing the company for a list change to Nasdaq First North.

About Redsense Medical
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense system, a medical technology product used for monitoring and alarm in the case of blood leakage in connection with hemodialysis. Redsense solves one of the most serious remaining safety problems within hemodialysis – to quickly detect venous needle dislodgement and catheter leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.